Paul T. Nghiem, MD, PhD
I enjoy getting to know my patients, understanding their lifestyle and explaining the latest science and available therapies. Our multidisciplinary team brings together leading researchers and cancer specialists to ensure that you are offered the most innovative treatment options. I emphasize education and will share my knowledge and experience with you, so you are able to make the best decisions about your care.
In addition to seeing patients in my office, I consult with patients from other parts of the country and their physicians who want expert guidance. Extensive consultation lets me look at the whole picture, consider all treatment options and customize patient care. I can successfully work with your local physician, allowing you to be treated where you live.
When I was a new attending physician, a mentor recruited me to help write a textbook chapter on Merkel cell carcinoma (MCC). I had seen only one case of MCC and knew very little about it. As I dug into the existing studies on MCC, my interest grew. I discovered that MCC is a unique cancer that strikes aggressively and is managed differently, has distinct risk factors and is the most lethal of all skin cancers. Since then, unraveling the mysteries of MCC has become the major focus of my clinical work and research.
Graft-versus-host disease, skin cancers, skin conditions related to cancer treatment
I am part of the Fred Hutch Multidisciplinary Skin Oncology Clinic, and I hope to continue expanding the clinic’s focus to include a greater breadth of skin cancers and dermatology. I am excited about recent discoveries in skin cancer research that will improve patient care.
In addition to seeing patients, I lead a lab at UW Medicine that studies the biology of Merkel cell carcinoma. Our goal is to develop new approaches to treating this disease.
Dr. Nghiem has received this peer-nominated award for his exceptional patient care multiple years in a row.
We make promising new treatments available to you through studies called clinical trials led by Fred Hutch doctors. Many of these trials at Fred Hutch have led to FDA-approved treatments and have improved standards of care globally. Together, you and your doctor can decide if a study is right for you.
Our providers are often asked to give their medical expertise for press and news publications. Read articles by or about this Fred Hutch provider.
SCCA’s Paul T. Nghiem, MD, PhD, and Michi M. Shinohara, MD, were named to Seattle Magazine’s list of Top Doctors in Seattle for 2021, recognizing their excellence in dermatology for skin cancer.
Your care team
Fred Hutch accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.